|
FASTKD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-15 |
| Normal-vs-Stage2 |
5.484600E-03 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
2.662100E-02 |
| Stage1-vs-Stage3 |
3.605000E-03 |
| Stage1-vs-Stage4 |
1.50780000000017E-05 |
| Stage2-vs-Stage3 |
6.019400E-04 |
| Stage2-vs-Stage4 |
3.67900000000088E-05 |
| Stage3-vs-Stage4 |
1.156390E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.25499968592646E-10 |
| Normal-vs-Asian |
1.11469999997116E-06 |
| Caucasian-vs-AfricanAmerican |
7.648400E-01 |
| Caucasian-vs-Asian |
3.790100E-02 |
| AfricanAmerican-vs-Asian |
1.082630E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64912528077821E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
8.627600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62803104331033E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
5.1222004415763E-10 |
| Normal-vs-Age(81-100Yrs) |
4.88369999995797E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.657600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.951000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.343200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.931170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.548400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.598000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.29000000021118E-07 |
| Classical-VS-Follicular |
2.07740000002232E-06 |
| Classical-VS-Other |
7.235000E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
4.30344648805203E-12 |
| Tall-VS-Other |
5.666100E-02 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
2.084600E-01 |
| Follicular-VS-Normal |
1.724310E-03 |
| Other-VS-Normal |
3.247500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.66453525910038E-15 |
| Normal-vs-N1 |
4.66293670342566E-15 |
| N0-vs-N1 |
1.035440E-01 |
|
|
